The Allergy & Asthma Network has congratulated lawmakers in states across the country for the aggressive expansion of access legislation that has made it easier to get epinephrine in public places.
AAN notes that this year, 16 states were added to the list of states which allow public venues to maintain epinephrine auto-injectors without a person-specific prescription. The 16 states that passed legislation this year make a total of 19 in all with such laws.
The latest two states to join were New Jersey and Michigan, whose legislatures passed bills regarding public access to epinephrine just before the holidays. Those laws are awaiting signature by the states’ governors.
AAN looks forward to 2016.
With the expansion of epinephrine access in 19 states to-date, AAN says that they are looking forward to helping lobby for more in others. Several states have legislation pending introduction in 2016.
“When someone is experiencing an anaphylactic reaction, minutes count and immediate access to epinephrine is critical,” said Tonya Winders, President and CEO of Allergy & Asthma Network. “By ensuring businesses have the option to stock epinephrine on their premises in case of an allergic reaction, patrons will be protected, whether they have a known allergen or experience a first-time reaction.”